Louis Artime

Some of the more significant engagements in which Mr. Artime has been involved include:

• Dai-ichi Life Holdings, Inc. in its acquisition of a 19.9% strategic minority stake in Canyon Partners, LLC
• Otsuka Pharmaceutical Co., Ltd. in its:
  • acquisition of Transcend Therapeutics, Inc. for US$700 million upfront and up to US$525 million in future milestone payments
  • acquisition of Jnana Therapeutics Inc. for US$800 million upfront and up to US$325 million in future milestone payments
  • acquisition of Visterra, Inc. for US$430 million
  • acquisition of Avanir Pharmaceuticals, Inc. for US$3.5 billion
  • acquisition of Astex Pharmaceuticals, Inc. for US$886 million
• DuPont de Nemours, Inc. in the US$1.8 billion sale of its Aramids business to Arclin
• Seven & i Holdings Co., Ltd. in an unsolicited bid by Alimentation Couche-Tard
• JX Advanced Metals Corporation (f/k/a JX Nippon Mining & Metals Corporation) in its:
  • acquisition of the remaining 48.5% stake in Caserones Copper Mine in Chile from Mitsui & Co., Ltd. and Mitsui Mining & Smelting Co., Ltd.
  • US$950 million sale of a 51% stake in SCM Minera Lumina Copper Chile to Lundin Mining Corporation and subsequent US$350 million sale of an additional 19% stake in SCM Minera Lumina Copper Chile to Lundin Mining Corporation and US$215 million sale of a 5% stake in SCM Minera Lumina Copper Chile to LMC Caserones SpA (Chile). Concurrently, LMC acquired the copper mine development project in the Frontera area from JX Advanced Metals
  • strategic partnership in Brazil with AMG Advanced Metallurgical Group N.V.
  • take-private of Toho Titanium Co., Ltd.
• Astroscale Holdings, Inc. in its ¥21 billion (US$135 million) Rule 144A/Regulation S IPO of its common stock and listing on the Tokyo Stock Exchange. This is the first IPO by a space debris removal company
• Sumitomo Mitsui Banking Corporation (SMBC) in its:
  • acquisition of up to a 15% stake in Jefferies Financial Group Inc., and the enhancement of its strategic alliance with Jefferies, in connection with which SMBC and Jefferies will collaborate across key growth areas, including M&A equity capital markets and debt capital markets advisory services in the U.S.
  • US$1.1 billion acquisition of Flagship Rail Services LLC
• Square Enix Holdings Co., Ltd. in its $300 million divestiture of select overseas studios and intellectual property to Sweden-based Embracer Group AB
• Appier Group, Inc. in its ¥29.8 billion (US$272 million) initial public offering on the Tokyo Stock Exchange
• the joint venture by Buzzfeed Inc. with Yahoo Japan Corporation to establish Buzzfeed Japan
• the acquisition by Furukawa Electric Co. Ltd. of SuperPower Inc. from the Philips Group
• the $4.2 billion spin-off and joint venture by Intel Corporation with TPG Capital, L.P. to form the independent cybersecurity company McAfee
• the joint venture agreement by The Japan Atomic Power Company with Exelon
• the underwriters in Mitsubishi Corporation’s US$500 million debt offering
• the underwriters in Japan Bank for International Cooperation’s multiple debt offerings (guaranteed by the Japanese government)
• the restructuring sponsorship by Key Safety Systems of Takata Corporation
• an agreement by Miraca Holdings, Inc. to form a genetic testing service joint venture company with Baylor College of Medicine
• the £844 million acquisition by Nikkei Inc. of the Financial Times Group from Pearson PLC
• the underwriters in Nippon Life Insurance Company’s $1.6 billion debt offering
• the acquisition by Nippon Shokubai Co., Ltd. of Sirrus, Inc.
• Olympus Corporation in its sale of its subsidiary Olympus Systems Corporation to Accenture Japan Ltd.
• the $173 million acquisition by Pacific Industrial Co., Ltd. of the Schrader valves business from Sensata Technologies Holdings plc
• Sanken Electric Co., Ltd. in the unsolicited, partial tender offer launched by the fund managed by Effssimo Management Capital (an Asian activist shareholder)
• Sekisui Chemical Co., Ltd. in its $510 million acquisition of AIM Aerospace Corporation
• Toshiba Corporation (alone or through its subsidiaries) in the take-private of three publicly traded subsidiaries

Mr. Artime joined the Corporate Group of Skadden’s Tokyo office in March 2014 from the firm’s New York office, where he practiced in the Mergers and Acquisitions and Intellectual Property and Technology groups since 2010.

Mr. Artime took leave from Skadden from September 2012 to June 2013 in order to complete advanced Japanese language study at the Inter-University Center for Japanese Language Studies in Yokohama, Japan, administered by Stanford University.